Mallinckrodt Pharmaceuticals and Endo have agreed to combine in a nearly $7bn deal after the pair emerged from bankruptcy processes linked to liabilities over the US opioid crisis.

The opioid epidemic is one of the most devastating public health crises in American history. Sadly, the crisis was a man-made disaster fueled by corporate greed, deception and negligence. As we ...

Welcome to the Winter 2025 issue of “FCA Enforcement & Compliance Digest,” our quarterly newsletter in which we compile essential updates on ...

Plus, pharmacy groups famed for opioid bankruptcies join forces and the mysterious Deutsche Bank employee making more than its CEO ...

BOSTON (AP) — McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work to help opioids manufacturer Purdue Pharma boost the sales of the highly ...

Prior to 60 Minutes' March 9, 2025 broadcast, which featured correspondent Cecilia Vega's report on the Purdue Pharma ...

Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy ...

"71 out of 72 Wisconsin counties filed lawsuits against Purdue Pharma. Brad Schimel refused to join them," the ad states. That refers to litigation launched around 2017 in Wisconsin and nationwide ...